Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study

Ruilope, LM; Pitt, B; Anker, SD; Rossing, P; Kovesdy, CP; Pecoits, R; Pergola, P; Joseph, A; Lage, A; Mentenich, N; Scheerer, MF; Bakris, GL

Ruilope, LM (通讯作者)，Inst Res Imas12, Cardiorenal Translat Lab, Madrid, Spain.;Ruilope, LM (通讯作者)，Inst Res Imas12, Hypertens Unit, Madrid, Spain.;Ruilope, LM (通讯作者)，Hosp Univ 12 Octubre, CIBER CV, Madrid, Spain.;Ruilope, LM (通讯作者)，European Univ Madrid, Fac Sport Sci, Madrid, Spain.;Bakris, GL (通讯作者)，Univ Chicago Med, Dept Med, Chicago, IL 60637 USA.

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023; 38 (2): 372

Abstract

Background In FIGARO-DKD, finerenone reduced the risk of cardiovascular events in patients with type 2 diabetes (T2D) and stage 1-4 chronic kidney dis......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索